Coexistence of Activating BRAF and KRAS Mutations in Lung Cancer Patients

被引：0
|
作者：
Wang, Y. [1 ]
机构：
[1] Beijing Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
BRAF; coexistence; KRAS;
D O I：
10.1016/j.jtho.2018.08.902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.13-45
引用
收藏
页码：S599 / S600
页数：2
相关论文
共 50 条
  • [41] Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer
    Helgi Birgisson
    Karolina Edlund
    Ulrik Wallin
    Lars Påhlman
    Hanna Göransson Kultima
    Markus Mayrhofer
    Patrick Micke
    Anders Isaksson
    Johan Botling
    Bengt Glimelius
    Magnus Sundström
    BMC Cancer, 15
  • [42] Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations
    Tissot, Claire
    Couraud, Sebastien
    Tanguy, Ronan
    Bringuier, Pierre-Paul
    Girard, Nicolas
    Souquet, Pierre Jean
    LUNG CANCER, 2016, 91 : 23 - 28
  • [43] Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond
    Katsios, Christos
    Ziogas, Dimosthenis E.
    Roukos, Dimitrios H.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (05) : 525 - 529
  • [44] Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions
    Yi, Chenghao
    Huang, Yanqing
    Yu, Xing
    Li, Xiaofen
    Zheng, Shu
    Ding, Kefeng
    Xu, Jinghong
    ONCOTARGET, 2016, 7 (13) : 17265 - 17274
  • [45] Origin and prognostic value of circulating KRAS mutations in lung cancer patients
    Gautschi, O.
    Huegli, B.
    Ziegler, A.
    Gugger, M.
    Heighway, J.
    Ratschiller, D.
    Mack, P. C.
    Gumerlock, P. H.
    Kung, H. J.
    Stahel, R. A.
    Gandara, D. R.
    Betticher, D. C.
    CANCER LETTERS, 2007, 254 (02) : 265 - 273
  • [46] Colorectal Cancer Prognosis Is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study
    Lee, Joon-Hyop
    Ahn, Jiyoung
    Park, Won Seo
    Choe, Eun Kyung
    Kim, Eunyoung
    Shin, Rumi
    Heo, Seung Chul
    Jung, Sohee
    Kim, Kwangsoo
    Chai, Young Jun
    Chae, Heejoon
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (01)
  • [47] Tumor profiling of KRAS, BRAF, and NRAS gene mutations in patients with colorectal cancer: A Lebanese major center cohort study
    Baba, Omar
    Bidikian, Aram
    Mukherji, Deborah
    Shamseddin, Ali
    Temraz, Sally
    Fakhruddin, Najla
    Khazzouh, Mira
    Ghizzawi, Diana
    Khalek, Rabab Abdel
    Zaatari, Ghazi
    Mahfouz, Rami
    GENE, 2022, 834
  • [48] Frequencies and Prognostic Role of KRAS and BRAF Mutations in Patients With Localized Pancreatic and Ampullary Adenocarcinomas
    Schultz, Nicolai Aagaard
    Roslind, Anne
    Christensen, Ib J.
    Horn, Thomas
    Hogdall, Estrid
    Pedersen, Lisbeth N.
    Kruhoffer, Mogens
    Burcharth, Flemming
    Wojdemann, Morten
    Johansen, Julia S.
    PANCREAS, 2012, 41 (05) : 759 - 766
  • [49] EGFR, KRAS and BRAF mutations in Chinese patients with clear cell renal cell carcinoma
    Wen, Shuang
    Li, Mei
    Liu, Zhi-Min
    Liu, Li-Sha
    Tian, Can
    Shao, Xiao-Qing
    Lv, Shen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (01): : 578 - 586
  • [50] Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patients
    Kollermann, J.
    Albrecht, H.
    Schlomm, T.
    Huland, H.
    Graefen, M.
    Bokemeyer, C.
    Simon, R.
    Sauter, G.
    Wilczak, W.
    ONCOLOGY LETTERS, 2010, 1 (04) : 729 - 732
12345